Resources Contact Us Home
Browse by: INVENTOR PATENT HOLDER PATENT NUMBER DATE
 
 
Browse by Category: Main > Chemistry
Class Information
Number: 536/24.5
Name: Organic compounds -- part of the class 532-570 series > Organic compounds (class 532, subclass 1) > Carbohydrates or derivatives > Nitrogen containing > N-glycosides, polymers thereof, metal derivatives (e.g., nucleic acids, oligonucleotides, etc.) > Dna or rna fragments or modified forms thereof (e.g., genes, etc.) > Nucleic acid expression inhibitors
Description: Fragments of DNA or RNA which are effective inhibitors of transcription or translation.


Patents under this class:

Patent Number Title Of Patent Date Issued
7619081 siRNA targeting coatomer protein complex, subunit beta 2 (COPB2) Nov. 17, 2009
7618947 Modulation of HIF-1 beta expression Nov. 17, 2009
7615627 RNA interference mediated inhibition of aurorakinase B and its combinations as anticancer therapy Nov. 10, 2009
7615626 Methods, agents, and compound screening assays for inducing differentiation of undifferentiatied mammalian cells into osteoblasts Nov. 10, 2009
7615619 Nucleoside analogues and oligonucleotide derivative comprising nucleotide analogue thereof Nov. 10, 2009
7615540 Formulations comprising antisense nucleotides to connexins Nov. 10, 2009
7615538 Method for therapy of rheumatoid arthritis Nov. 10, 2009
7612196 siRNA targeting cyclin-dependent kinase inhibitor 1B (p27, Kip1) (CDKN1B) Nov. 3, 2009
7612195 Retroviral vectors for delivery of interfering RNA Nov. 3, 2009
7612194 Nucleic acid sequences from Diabrotica virgifera virgifera LeConte and uses thereof Nov. 3, 2009
7612185 Nucleic acid biosensors Nov. 3, 2009
7611723 Stinging cells expressing an exogenous polynucleotide encoding a therapeutic, diagnostic or a cosmetic agent and methods compositions and devices utilizing such stinging cells or capsules deri Nov. 3, 2009
7608707 siRNA targeting survivin Oct. 27, 2009
7608706 siRNA targeting ras-related nuclear protein Oct. 27, 2009
7608705 Oligonucleotides, agents containing these oligonucleotides, and the use thereof Oct. 27, 2009
7608698 Hypoxia inducible factors and uses thereof for inducing angiogenesis and improving muscular functions Oct. 27, 2009
7605252 siRNA targeting kinase insert domain receptor (KDR) Oct. 20, 2009
7605251 Compositions and methods for inhibiting expression of the PCSK9 gene Oct. 20, 2009
7605250 siRNA targeting cAMP-specific phosphodiesterase 4D Oct. 20, 2009
7605249 Treatment of neurodegenerative disease through intracranial delivery of siRNA Oct. 20, 2009
7604977 Methods and compositions for inhibiting HIV infection Oct. 20, 2009
7601700 Modulation of eIF4E expression Oct. 13, 2009
7601699 Production of reprogrammed cells with restored potential Oct. 13, 2009
7601696 Oct-1 as an oncoprotein and use of nucleic acid inhibitors of Oct-1 for cancer treatment Oct. 13, 2009
7601501 Controlling osteogenesis by inhibition of osteogenic suppressors Oct. 13, 2009
7601494 Method of screening candidate compounds for susceptibility to biliary excretion Oct. 13, 2009
7601367 Compositions and processes using siRNA, amphipathic compounds and polycations Oct. 13, 2009
7598370 siRNA targeting polo-like kinase-1 (PLK-1) Oct. 6, 2009
7598369 siRNA targeting histamine receptor H1 Oct. 6, 2009
7595389 siRNA targeting casitas B cell lymphoma-B (CBL-B) Sep. 29, 2009
7595388 siRNA targeting EPH receptor A3 (EPHA3) Sep. 29, 2009
7595387 Modified polynucleotides for reducing off-target effects in RNA interference Sep. 29, 2009
7595386 Methods and compositions for heat activated gene therapy using cytolethal distending toxin Sep. 29, 2009
7595306 Method of treating neurodegenerative disease Sep. 29, 2009
7595304 Polymeric oligonucleotide prodrugs Sep. 29, 2009
7595301 Staple type oligonucleotide and drug comprising the same Sep. 29, 2009
7592505 UDP-xylose synthases (UXS) polynucleotides, polypeptides, and uses thereof Sep. 22, 2009
7592446 Synthesis of selenium-derivatized nucleosides, nucleotides, phosphoramidites, triphosphates and nucleic acids Sep. 22, 2009
7592444 siRNA targeting myeloid cell leukemia sequence 1 Sep. 22, 2009
7592443 siRNA targeting interleukin-1 receptor-associated kinase 4 (IRAK4) Sep. 22, 2009
7592442 siRNA targeting ribonucleotide reductase M2 polypeptide (RRM2 or RNR-R2) Sep. 22, 2009
7592441 Liver cancer-related nucleic acids Sep. 22, 2009
7592440 Methods of obtaining active antisense compounds Sep. 22, 2009
7592324 RNAi-mediated inhibition of ocular targets Sep. 22, 2009
7592323 TRPM-2 antisense therapy Sep. 22, 2009
7592322 RNAi modulation of RSV, PIV and other respiratory viruses and uses thereof Sep. 22, 2009
7592319 Uses of DNA-PK Sep. 22, 2009
7592318 88kDa tumorigenic growth factor and antagonists Sep. 22, 2009
7589191 siRNA targeting hypoxia-inducible factor 1 Sep. 15, 2009
7589190 Potent LNA oligonucleotides for the inhibition of HIF-1A expression Sep. 15, 2009



 
 
  Recently Added Patents
Calathea plant named `PP0005`
Display apparatus having precharge capability
Stabilized body care products, household products, textiles and fabrics
Movable vehicle roof assembly
Process for the preparation of 3-spiro'cyclohexan-1,3'-'3H!indolin-2'-one! derivatives
Fluid coupling assembly
Wideband active-passive differential signal probe
  Randomly Featured Patents
Crosslinkable and crosslinked polymers
Bar pry bottle opener
Ophthalmic lenses with heterocyclic chromene compounds
Highly amorphous olefin terpolymer
Particle inspection device and inspection method using the same
Video game cartridge recognition and security system
Arrangement for compensating for temperature dependent variations in surface resistance of a resistor on a chip
Orientation station for multi-station metal-forming machines
Method for producing ammoxidation catalyst
Method for enhancing germination